BioHealth News Archive
Previous BHCR Crab Trap Winner Nanochon Announces Health Canada Approval for First Human Investigation
Washington, DC, July 10 2025 – Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage…
Read MoreJohns Hopkins’ Robot Performs First Autonomous Surgery
by Jill Rosen - A robot trained on videos of surgeries performed a lengthy phase of a gallbladder removal without human help. The robot operated…
Read MoreBioBytes Episode 34: How to Launch a Biotech Startup in 2025 | Real Talk with Richard Bendis
Getting a biotech company off the ground takes more than science; it takes strategy, funding, and the right network. In this episode, I’m joined…
Read MoreEmergent Secures $51.9M Contract for Smallpox Vaccine Treatment in U.S. Biodefense Effort
GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous…
Read MoreConnect Capital and Innovation at the BioHealth Capital Region Investment Conference on September 25, 2025 at US Pharmacopeia, Rockville, MD
The Annual BioHealth Capital Region Investment Conference is the premier destination for discovering emerging companies that are redefining what’s possible in life sciences. Taking…
Read MoreMaryland Tech Council Launches Rural Technology Network to Accelerate Rural Innovation
ROCKVILLE, Md.--(BUSINESS WIRE)--The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, today announced the launch of the…
Read MoreReimagining Gene and Cell Therapy: Helen Sabzevari on Precigen’s Breakthroughs in Precision Medicine on BioTalk
In this episode of BioTalk, Rich Bendis welcomes Dr. Helen Sabzevari, President and CEO of Precigen, to discuss the company’s cutting-edge science in gene…
Read MoreGain Therapeutics Completes Enrollment for Parkinson’s Drug Study
BETHESDA, Md., June 30, 2025 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…
Read MoreGeorge Mason is part of Northern Virginia’s first innovation district, launched with transformational grant from GO Virginia
Thanks to a major investment from GO Virginia, Northern Virginia’s first Innovation District is taking shape, laying the groundwork for growth in high-tech industry…
Read More